Multiple Sclerosis Quiz: Symptom Pattern Screener
- Screener
- About 4 min
- Original items on MS presenting symptoms, informed by the McDonald criteria
- Runs in your browser, nothing is sent
- Medical review: Medical review pending
If your symptoms are severe or sudden, seek urgent medical care.
Start the testThree things this quiz separates
Most people who search for an MS quiz do not have MS; tingling, fatigue and brain fog have dozens of causes. What makes MS different is the shape of the episodes: distinct neurological events, lasting days or more, in different parts of the nervous system, at different times. Scoring the symptoms and the pattern apart is what makes the result useful.
-
12
Presenting symptoms
-
4
A breakdown by body system
-
3
The episode pattern
How this compares with a typical online quiz
| Feature | Typical free quiz | Regenerated.com |
|---|---|---|
| Items built around how MS actually presents | Sometimes | Yes, original items on the recognized presenting symptoms |
| Episode pattern scored separately | Rarely | Yes, three items on dissemination in time and place |
| Body-system breakdown | No | Vision, sensation, movement, general |
| Names the look-alikes | No | Yes, from the 2023 consensus on conditions mistaken for MS |
| Says what a neurologist will do | Rarely | Yes, examination, MRI, blood tests, sometimes a lumbar puncture |
| Email required for the result | Often | Never |
| Answers sent to a server | Often | Never; scored in your browser, counts-only events |
What points toward MS, and what the criteria require
Multiple sclerosis is identified by evidence of inflammation in the central nervous system that is spread out in place and in time: lesions in more than one of the typical regions (around the ventricles, under the cortex, in the brainstem and cerebellum, and in the spinal cord), and either more than one episode or MRI signs that new and old lesions coexist. That is the core of the McDonald criteria, revised in 2017 and again in 2024, which also allow specific markers in the spinal fluid, such as oligoclonal bands, to stand in for a second episode. No symptom on its own meets the criteria; the pattern, the MRI and the exclusion of other causes do.
The symptoms this quiz scores are the ones MS most often opens with. A painful blur or dimming in one eye over days (optic neuritis), a shock-like sensation on bending the neck (Lhermitte's sign), a band of numbness or tingling, weakness in a limb, unsteadiness or vertigo lasting days, and worsening with heat (Uhthoff's phenomenon) are classic because each reflects a lesion in a particular place. Fatigue, bladder change and thinking problems are common in MS but common in many other conditions too, which is why they sit in the general category and carry less weight in the breakdown's story.
Conditions that produce the same symptoms
A 2023 international consensus led by Solomon lists the conditions most often mistaken for MS and the red flags that point away from it. Migraine, especially with aura, produces visual disturbance, numbness and tingling that last minutes to an hour. Vitamin B12 deficiency causes numbness, unsteadiness and fatigue and is found on a blood test. Peripheral neuropathy, carpal tunnel and a pinched nerve in the neck cause tingling in a glove or stocking pattern or along one nerve. Anxiety and panic produce tingling, dizziness and a sense of unreality. Fibromyalgia and chronic fatigue produce fatigue, pain and brain fog without the episodic neurological pattern. Lyme disease, lupus, sarcoidosis, neuromyelitis optica spectrum disorder and MOG antibody disease can all mimic MS and need their own tests. Small-vessel disease in older adults produces MRI spots that are not MS.
That list is why a neurologist, not a quiz, gives the answer, and it is also why a high score on this page is not a verdict. Many of these alternatives are more common than MS and several are easier to treat.
What happens at a neurology visit
Expect a detailed history of each episode (when it started, how fast, how long, what it affected), a neurological examination that checks the eyes, reflexes, strength, sensation, coordination and gait, and blood tests for the look-alikes, commonly B12, thyroid, inflammatory markers and, depending on history, Lyme and autoimmune antibodies. The central test is an MRI of the brain and usually the spinal cord, with contrast, read for lesions in the typical places and for signs of old and new activity. Where the MRI is suggestive but not conclusive, a lumbar puncture to look for oligoclonal bands, and sometimes visual evoked potentials or optical coherence tomography of the retina, add evidence.
If MS is confirmed, treatment has changed a great deal: more than twenty disease-modifying therapies now reduce relapses and slow the build-up of disability, and the evidence favors starting early. That is the practical reason not to wait on a convincing episode. Anyone with sudden loss of vision, sudden weakness or numbness on one side, difficulty speaking or severe unsteadiness should be assessed at once, because those are also the signs of stroke and other emergencies.
Methodology and sources
The twelve symptom items are original wording written to cover the presenting symptoms of multiple sclerosis described in the clinical literature, with the typical lesion sites of the McDonald criteria (optic nerve, periventricular, juxtacortical, infratentorial and spinal cord) as the organizing frame: optic neuritis, diplopia, Lhermitte's sign, sensory bands and limb numbness, trigeminal symptoms, limb weakness, ataxia and vertigo, Uhthoff's phenomenon, fatigue, bladder dysfunction and cognitive change. The three pattern items follow the dissemination-in-time and dissemination-in-space logic of the 2017 McDonald revisions by Thompson and colleagues. The McDonald criteria are a diagnostic framework for clinicians using MRI and spinal fluid, not a questionnaire, and nothing here reproduces any published instrument. The items ask what actually happened over the past two years, in concrete situations, with their own response labels, and the bands are educational.
Scoring: each symptom item is answered No or Not sure (0), Yes, one episode (1), or Yes, more than one episode or ongoing (2), for a total of 0 to 24. Items are grouped as vision (2), sensation (3), movement and balance (3) and general (4) and the breakdown sums each group. The three pattern items are yes/no and are counted separately. Two answers raise the result to at least the band that advises a neurology visit regardless of the total: a yes to the optic neuritis item, because painful one-eyed visual loss warrants prompt assessment in its own right, and a yes to two or more separate episodes in different parts of the body, because that is the pattern the criteria are built on. The band boundaries (0 to 2, 3 to 7, 8 to 13, 14 to 24) were chosen for readability and have not been validated against a neurologist's diagnosis.
This is an educational screener. Symptom questionnaires cannot see lesions, and the symptoms scored here are shared with migraine, B12 deficiency, neuropathy, anxiety, fibromyalgia, Lyme disease and several other conditions, most of them more common than MS. A neurologist makes the distinction with an examination, MRI and blood tests. A low score does not exclude MS, which sometimes presents with a single symptom; a high score does not confirm it.
Medical review: Medical review pending. Last updated .
References
- Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi:10.1016/S1474-4422(17)30470-2
- Solomon AJ, Arrambide G, Brownlee WJ, et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023;22(8):750-768. doi:10.1016/S1474-4422(23)00148-5
- Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336-1346. doi:10.1016/S0140-6736(16)30959-X
- Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029-e1040. doi:10.1212/WNL.0000000000007035